China Health Industries Holdings Inc (CHHE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CHHE Annual Balance Sheets →
The balance sheet data below highlights changes in China Health Industries Holdings Inc's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Receivables, Net, Current0.00
Inventories0.00
Other Current Assets0.24
Prepaid Expense, Current AS0.00
Total Current Assets0.25
Equipment/Property/Plant Net2.50
Intangible Assets0.96
Other Assets, Noncurrent0.42
Total Assets4.13
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.29
Accrued Salaries, Current0.11
Short-term Debt DE10.03
Other Liabilities, Current5.60
Taxes Payable, Current, Total0.15
Customer Advances, Current0.34
Total Current Liabilities6.53
Total Long-term Debt0.00
Total Liabilities6.53
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock0.52
Retained Earnings / Accumulated Deficit40.52
Other Equity-43.44
Common Stockholder's Equity-2.40
Total Stockholder's Equity-2.40
Liabilities & Stockholder's Equity4.13
4 historic quarters locked

Sign in to unlock the full China Health Industries Holdings Inc balance sheet history.

About China Health Industries Holdings Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-24-055976

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.